Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma.

ABSTRACT: Pluripotent cells have been used to probe developmental pathways that are involved in genetic diseases and oncogenic events. To find new therapies that would target MYB-driven tumors, we developed a pluripotent zebrafish blastomere culture system. We performed a chemical genetic screen and identified retinoic acid agonists as suppressors of c-myb expression. Retinoic acid treatment also decreased c-myb gene expression in human leukemia cells. Translocations that drive overexpression of the oncogenic transcription factor MYB are molecular hallmarks of adenoid cystic carcinoma (ACC), a malignant salivary gland tumor with no effective therapy. Retinoic acid agonists inhibited tumor growth in vivo in ACC patient-derived xenograft models and decreased MYB binding at

SUBMITTER: Mandelbaum J 

PROVIDER: S-EPMC6170170 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature